Fangzhou Inc. Joins Sun Yat-sen University in Securing NSFC Grant for AI-Driven Healthcare Research

Reuters
Sep 03
Fangzhou Inc. Joins Sun Yat-sen University in Securing NSFC Grant for AI-Driven Healthcare Research

Fangzhou Inc., a leader in AI-driven Internet healthcare solutions, has secured approval for its second project backed by the National Natural Science Foundation of China (NSFC). The project, led by Sun Yat-sen University professor Liang Jianping, marks a collaborative effort with Fangzhou as the sole corporate partner. The research focuses on human-AI collaboration models in consumer adoption of healthcare products. This approval aligns with China's strategic priority to advance AI across key sectors, including healthcare. Fangzhou's involvement underscores its commitment to integrating academic research with industry expertise, contributing to the "Healthy China 2030" goals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fangzhou Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9522375-en) on September 03, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10